0.5% bupivacaine
0.5% bupivacaine is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Repetitive GON Blockade for Menstrual Migraine
Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)
Stellate Ganglion Block
Exparel vs Block for ACL Reconstruction
Bupivacaine for Benign Headache in the ED
Clinical Trials (10)
Repetitive GON Blockade for Menstrual Migraine
Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)
Stellate Ganglion Block
Exparel vs Block for ACL Reconstruction
Bupivacaine for Benign Headache in the ED
Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)
Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction
Post-Op Rotator Cuff Pain Study With Subacromial Bupivacaine Infusion
Evaluation of Deep Topical Fornix Nerve Block Versus Topical Anaesthesia Procedure
Efficacy and Cost: Benefit Ratio of 0, 1, and 2 Medial Branch Blocks for Lumbar Facet Joint Radiofrequency Denervation
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10